Systems biology approach for subtyping asthma; Where do we stand now?

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 1, 2014, Pages 17-22

  Kaminsky, David A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

cluster analysis; multiscale models of asthma; network medicine; systems biology; systems medicine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5;

ADAPTIVE IMMUNITY; ASTHMA; BODY MASS; CALCIUM SIGNALING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEALTH CARE UTILIZATION; HELPER CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG FUNCTION; ONSET AGE; PHENOTYPE; PRACTICE GUIDELINE; PROTEIN INTERACTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMS BIOLOGY; TREATMENT RESPONSE; UPREGULATION;

ASTHMA; GENE-ENVIRONMENT INTERACTION; HUMANS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; PHARMACOGENETICS; PROTEIN INTERACTION MAPS; SYSTEMS BIOLOGY;

EID: 84890119198     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000004     Document Type: Review

References (67)

1. Rackeman F. A working classification of asthma. Am J Med 1947; 33:601-606
2. Auffray C, Adcock I, Chung K, et al. An integrative systems biology approach for understanding of pulmonary diseases. Chest 2010; 137:1410-1416
3. Kaminsky D, Irvin C, Sterk P. Complex systems in pulmonary medicine: A systems biology approach to lung disease. J Appl Physiol 2011; 110:1716-1722
4. Anderson G. Endotyping asthma: New insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008; 372:1107-1119
5. Lotvall J, Akdis C, Bacharier L, et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127:355-360
6. Aderem A. Systems biology: Its practice and challenges. Cell 2005; 121:511-513
7. Kitano H. Systems biology: A brief overview. Science 2002; 295:1662-1664
8. Ahn A, Tewari M, Poon C-S, Phillips R. The clinical applications of a systems approach. PLoS Med 2006; 3:956-960
9. Macklem P. Emergent phenomena and the secrets of life. J Appl Physiol 2008; 104:1844-1846
10. Studer S, Kaminski N. Towards systems biology of human pulmonary fibrosis. Am J Respir Crit Care Med 2007; 4:85-91
11. Barabasi A-L. Network medicine-from obesity to the 'diseasome'. N Engl J Med 2007; 357:404-407
12. Christakis N, Fowler J. The collective dynamics of smoking in a large social network. N Engl J Med 2008; 358:2249-2258
13. Auffray C, Chen Z, Hood L. Systems medicine: The future of medical genomics and healthcare. Genome Med 2009; 1:2.1-2.11
14. Barabasi A-L, Gulbahce N, Loscalzo J. Network medicine: A network-based approach to human disease. Nat Rev Genet 2011; 12:56-68
15. Wu W, Kaminski N. Chronic lung diseases. WIREs Syst Biol Med 2009; 1:298-308
16. Tan Z, Randall G, Fan J, et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Human Genet 2007; 81:829-834
17. Duan Q, Gaume B, Hawkins G, et al. Regulatory haplotypes in ARG1 are associated with altered bronchodilator response. Am J Respir Crit Care Med 2011; 183:449-454
18. Karczewski K, Dudley J, Kukurba K, et al. Systematic functional regulatory assessment of disease-Assoicated variants. Proc Natl Acad Sci U S A 2013; 110:9607-9612
19. Moffatt M, Gut I, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363:1211-1221
20. Renkonen J, Joenvaara S, Parviainen V, et al. Network analysis of single nucleotide polymorphisms in asthma. J Asthma Allergy 2010; 3:177-186
21. Grotenboer N, Ketelaar M, Koppelman G, Nawijn M. Decoding asthma: Translating genetic variation in IL-33 and IL-1RL1 into disease pathophysiology. J Allergy Clin Immunol 2013; 131:856-865
22. Dahlin A, Tantisira K. Integrative systems biology approaches in asthma pharmacogenomics. Pharmacogenomics 2012; 13:1387-1404
23. Kauffmann F, Demenais F. Gene-environment interactions in asthma and allergic diseases: Challenges and perspectives. J Allergy Clin Immunol 2012; 130:1229-1240
24. Gomes-Alves P, Imrie M, Gray R, et al. SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease. Clin Biochem 2010; 43:168-177
25. Fens N, Zwinderman A, Van Der Schee M, et al. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009; 180:1076-1082
26. Brasier A, Victor S, Boetticher G, et al. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-Derived cytokines. J Allergy Clin Immunol 2008; 121:30.e6-37.e6
27. O'Neil S, Sitkasuskiene B, Babusyte A, et al. Network analysis of quantitative proteomics on asthmatic bronchi: Effects of inhaled glucocorticoid treatment. Respir Res 2011; 12:124
28. Hwang S, Son S, Kim S, et al. A protein interaction newtork associated with asthma. J Theor Biol 2008; 252:722-731
29. Pillai R, Divekar R, Brasier A, et al. Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression. Curr Allergy Asthma Rep 2012; 12:388-395
30. Bhakta N, Woodruff P. Human asthma phenotypes: From the clinic, to cytokines, and back again. Immunol Rev 2011; 242:220-232
31. McGrath K, Icitovic N, Boushey H, et al. A large subgroup of mild-To-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185:612-619
32. Haldar P, Pavord I. Noneosinophilic asthma: A distinct clinical and pathologic phenotype. J Allergy Clin Immunol 2007; 119:1043-1052
33. Humbert M. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: Evidence against íntrinsic' asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154:1497-1504
34. Woodruff P, Modrek B, Choy D, et al. T-helper type 2-Driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180:388-395
35. Wenzel S. Asthma phenotypes: The evolution from clinical to molecular approaches. Nature Med 2012; 18:716-725
36. Wenzel SE, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013; 368:2455-2466
37. Pavord I, Korn S, Howarth P. Mepolizumab for severe eosinophilic asthma (DREAM): A multicenter, double-blind, placebo-controlled trial. Lancet 2013; 380:651-659
38. Corren J, Lemanske R, Hanania N, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011; 365:1088-1098
39. Piper E, Brightling C, Niven R. A phase II placebo controlled study of tralokinumab in moderate-To-severe asthma. Eur Respir J 2013; 41: 330-338
40. Dixon A, Holguin F, Sood A, et al. An official American Society Workshop report: Obesity in asthma. Proc Am Thorac Soc 2010; 7:325-335
41. Sidelva O, Black K, Dixon A. Effects of obesity and weight loss on airway physiology and inflammation in asthma. Pulm Pharmacol Ther 2013; 26:45-48
42. Holtzman M. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest 2012; 8:2741-2748
43. Woolcock A, Read J. Improvement in bronchial asthma not reflected in forced expiratory volume. Lancet 1965; 2:1323-1325
44. Venegas J, Winkler T, Musch G, et al. Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature 2005; 434:777-782
45. Frey U, Brodbeck T, Majumdar A, et al. Risk of severe asthma episodes predicted from fluctuation analysis of airway function. Nature 2005; 438: 667-670
46. Albert R. Scale-free networks in cell biology. J Cell Science 2005; 118: 4947-4957
47. Veiga J, Lopes A, Jansen J, Melo P. Fluctuation analysis of respiratory impedance waveform in asthmatic patients: Effect of airway obstruction. Med Biol Eng Comput 2012; 12:1249-1259
48. Farah C, King G, Brown N, et al. Ventilation heterogeneity predicts asthma control in adults following inhaled corticosteroid dose titration. J Allergy Clin Immunol 2012; 130:61-68
49. Wenzel S. Asthma: Defining the persistent adult phenotypes. Lancet 2006; 368:804-813
50. Haldar P, Pavord I, Shaw D, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-224
51. Moore W, Meyers D, Wenzel S, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181:315-323
52. Patrawalla P, Kazeros A, Rogers L, et al. Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population. PLOS one 2012; 7:e44540
53. Fitzpatrick AM, Teague WG, Meyers DA, et al. Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2011; 127:382-389
54. Amelink M, de Nijs S, de Groot J, et al. Three phenotypes of adult-onset asthma. Allergy 2013; 68:674-680
55. Siroux V, Basagana X, Boudier A, et al. Identifying adult asthma phenotypes using a clustering approach. Eur Respir J 2011; 38:310-317
56. Boudier A, Curjuric I, Basagana X, et al. 10 year follow up of cluster based asthma phenotypes in adults. A pooled analysis of three cohorts. Am J Respir Crit Care Med 2013; 188:550-560
57. Lauzon A-M, Bates J, Donovan G, et al. A multiscale approach to airway hyperresponsiveness: From molecule to organ. Front Physiol 2012; 3:1-25
58. Politi A, Donovan G, Tawhai M, et al. A multiscale, spatially distributed model of asthmatic airway hyper-responsiveness. J Theor Biol 2010; 266:614-624
59. Apiou-Sbirlea G, Katz I, Martonen T. The effects of simulated airway diseases and affected flow distribution on aerosol deposition. Respir Care 2010; 55:707-718
60. Lin C, Tawhai M, Hoffman E. Multiscale image-based modeling and simulation of gas flow and particle transport in the human lungs. Wiley Interdiscip Rev Syst Biol Med 2013; 5:643-655
61. Agusti A, Calverley P, Celli B, et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 10:122
62. Weston A, Hood L. Systems biology, proteomics, and the future of healthcare: Toward predictive, preventive, and personalized medicine. J Proteome Res 2004; 3:179-196
63. Richens J, Urbanowicz R, LUnt E, et al. Systems biology coupled with labelfree high-Throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease. Respir Res 2009; 10:29
64. Broadhurst D, Kell D. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006; 2:171-196
65. Clermont G, Auffray C, Moreau Y, et al. Bridging the gap between systems biology and medicine. Genome Med 2009; 1:88
66. Anto J, Pinart M, Akdis M, et al. Understanding the complexity of IgE-related phenotypes from childhood to young adulthood: A Mechanisms of the Development of Allergy (MeDALL) Seminar. J Allergy Clin Immunol 2012; 129:943-954
67. Sittka A, Vera J, Lai X, Schmeck B. Asthmaphenotyping, therapy and prevention: What can we learn from systems biology? Pediatr Res 2013; 73:543-552